Let's Talk ID

The COVID-19 pandemic has pushed the mental and emotional state of frontline clinicians to its limits. In this episode, hosted in partnership with the American College of Emergency Physicians, emergency medicine physician Anthony Cirillo, MD and Corey Feist of the Dr. Lorna Breen Heroes Foundation discuss what’s driving stress and burnout, immediate interventions that can be taken and how changes to health care policy and programs can protect the clinical workforce over the long-term.

IDSA President Daniel McQuillen, MD, FIDSA, IDSA President-Elect Carlos del Rio, MD, FIDSA and John Bridgeland, co-founder and CEO of the COVID Collaborative, discuss how to combat COVID-19 misinformation and the impact misinformation may have on the future of medicine.

How reliable are at-home COVID-19 tests? Are there shortcomings to “testing out” of vaccine mandates? IDSA members Dial Hewlett, MD, FIDSA of the Westchester County Health Department and Nira Pollock, MD, FIDSA of Boston Children’s Hospital join us to discuss the latest on COVID-19 testing. *This episode was recorded on December 6, 2021.

In this episode recorded on December 13th, IDSA President-Elect Carlos del Rio, MD, FIDSA and IDSA Public Health Committee Chair Julie Vaishampayan, MD, FIDSA share what the medical community knows thus far about the Omicron variant, including its impact on current COVID-19 treatments and why testing plays a key role.

Misinformation about COVID-19, including vaccines, treatments and the government’s role, has been fueling vaccine hesitancy. In this episode, IDSA President Dr. Daniel McQuillen, FIDSA, IDSA President-Elect Dr. Carlos del Rio, FIDSA and John Bridgeland, co-founder and CEO of the COVID Collaborative, discuss what is being done to combat misinformation, how to address myths with vaccine hesitant patients, the impact misinformation has on the future of medicine and the latest information on omicron.

COVID-19 Treatment Guideline co-authors Rajesh Gandhi, MD, FIDSA of Harvard University and Adarsh Bhimraj, MD, FIDSA of the Cleveland Clinic give an update on COVID-19 therapeutics and discuss two recently published papers in Clinical Infectious Diseases. Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab882/6398589 Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab880/6398590

Moderator Neil Skolnik, MD and IDSA COVID-19 Guidelines co-author John Lynch, MD, FIDSA discuss the new IDSA guidance on infection prevention for healthcare personnel caring for patients with suspected or known COVID-19. The Infectious Diseases Society of America's Guideline Podcast provides concise summaries of the most important IDSA guidelines. For the full version of the guidelines presented, please go to https://www.idsociety.org/practice-guideline/covid-19-guideline-infection-prevention/ (published 11/4/2021) Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health John B. Lynch, M.D. is a Professor in the Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington

In honor of Native American Heritage Month, COVID-19 Real-Time Learning Network Associate Editor Mati Hlatshwayo Davis, MD, MPH, leads a panel discussion with Luke John Day, MD of UCSF, Sophie Neuner, MD, MPH of Johns Hopkins Center for American Indian Health, and Jessica Snowden, MD, FIDSA of UAMS. The group discusses the importance of visibility of native people, historic and modern reasons for mistrust of the health care system, strategies for providing culturally inclusive care and the impact COVID-19 has had on native communities.

IDSA President Daniel McQuillen, MD, FIDSA is joined by Congresswoman Lori Trahan (D-MA) and IDSA Advocacy Liaison Kinna Thakarar, DO to discuss the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act, new bipartisan legislation that would provide loan repayment for medical professionals who work in bio-preparedness or provide infectious diseases care in underserved areas or clinics and facilities that receive federal funding.

Are current vaccination rates in the U.S. enough to bring an end to the pandemic? Keipp Talbot, MD, FIDSA of Vanderbilt University Medical Center and Amber Clayton of the Society for Human Resource Management join us to provide an update on COVID-19 vaccination and employer vaccine mandates.